跳至主要内容
临床试验/NCT06155370
NCT06155370尚未招募不适用

Construction of Gynecological Tumor Organoids

Peking Union Medical College Hospital0 个研究点目标入组 200 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
主要终点
Construction of BioBank

研究概览

简要总结

This study focuses on the construction of a biological sample library for organoids and tumor tissues in gynecological tumors.

详细描述

Explore the construction and maintenance of a large-scale queue of gynecological tumor organoids. Beijing Daxiang Technology Co., Ltd. provides corresponding technical support and chip design. Gynecological oncology center provides tumor samples, clinical information, and pathological support, and biological sample library provides technical support, storage space, and quality management.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age of 18 or older, an informed consent form is provided;
  • The preoperative tumor burden assessment and intraoperative researcher team believe that sampling is feasible;
  • Having relevant requirements for sample library storage;
  • Surgical treatment at Peking Union Medical College Hospital.

排除标准

  • Unable to meet all inclusion criteria;
  • The research team considers any situations or considerations that may hinder normal pathological assessment.

结局指标

主要结局

Construction of BioBank

时间窗: one year

BioBank including organoids banks, tissue banks, PDX banks, immune cell banks, and primary banks from other tissue sources

次要结局

  • Exploring the molecular mechanism based on organoids banks(one year)
  • Drug sensitivity detection based on organoids banks(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lei Li

professor

Peking Union Medical College Hospital

相似试验

Unknown
不适用
Tissue Bank of Biological Specimens From Patients With Gynecologic DiseaseEndometrial NeoplasmsUterine Cervical NeoplasmsOvarian NeoplasmsLeiomyoma
NCT00299481U.S. Army Medical Research and Development Command7,000
尚未招募
不适用
Construction of Gynecological Tumor Sample LibraryGynecologic Cancer
NCT06204354Peking Union Medical College Hospital2,500
已完成
不适用
Pre-Clinical Models in Gynecological Tumors A Tissue RepositoryEndometrial NeoplasmsUterine Neoplasms
NCT00250783University of New Mexico26
招募中
不适用
Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot StudyEndometrial Cancer
NCT06603506Centre Francois Baclesse16
已完成
不适用
Collecting Tumor Samples From Patients With Gynecological TumorsBorderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise SpecifiedChildhood Embryonal RhabdomyosarcomaChildhood Malignant Ovarian Germ Cell TumorEndometrioid Stromal SarcomaGestational Trophoblastic TumorMalignant MesotheliomaMalignant Ovarian Epithelial TumorNeoplasm of Uncertain Malignant PotentialOvarian Brenner TumorOvarian Clear Cell CystadenocarcinomaOvarian Serous CystadenocarcinomaPaget Disease of the VulvaMelanomaRecurrent Cervical CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Ovarian Germ Cell TumorRecurrent Primary Peritoneal CarcinomaRecurrent Uterine Corpus CarcinomaRecurrent Vaginal CarcinomaRecurrent Vulvar CarcinomaStage I Ovarian CancerStage I Uterine Corpus CancerStage I Vaginal CancerStage I Vulvar CancerStage IA Cervical CancerStage IA Fallopian Tube CancerStage IA Ovarian CancerStage IA Ovarian Germ Cell TumorStage IB Cervical CancerStage IB Fallopian Tube CancerStage IB Ovarian CancerStage IB Ovarian Germ Cell TumorStage IC Fallopian Tube CancerStage IC Ovarian CancerStage IC Ovarian Germ Cell TumorStage II Ovarian CancerStage II Uterine Corpus CancerStage II Vaginal CancerStage II Vulvar CancerStage IIA Cervical CancerStage IIA Fallopian Tube CancerStage IIA Ovarian CancerStage IIA Ovarian Germ Cell TumorStage IIB Cervical CancerStage IIB Fallopian Tube CancerStage IIB Ovarian CancerStage IIB Ovarian Germ Cell TumorStage IIC Fallopian Tube CancerStage IIC Ovarian CancerStage IIC Ovarian Germ Cell TumorStage III Borderline Ovarian Surface Epithelial-Stromal TumorStage III Cervical CancerStage III Uterine Corpus CancerStage III Vaginal CancerStage III Vulvar CancerStage IIIA Fallopian Tube CancerStage IIIA Ovarian CancerStage IIIA Ovarian Germ Cell TumorStage IIIA Primary Peritoneal CancerStage IIIB Fallopian Tube CancerStage IIIB Ovarian CancerStage IIIB Ovarian Germ Cell TumorStage IIIB Primary Peritoneal CancerStage IIIC Fallopian Tube CancerStage IIIC Ovarian CancerStage IIIC Ovarian Germ Cell TumorStage IIIC Primary Peritoneal CancerStage IV Borderline Ovarian Surface Epithelial-Stromal TumorStage IV Fallopian Tube CancerStage IV Ovarian CancerStage IV Primary Peritoneal CancerStage IV Uterine Corpus CancerStage IVA Cervical CancerStage IVA Vaginal CancerStage IVB Cervical CancerStage IVB Vaginal CancerStage IVB Vulvar CancerUterine Corpus CancerUterine Corpus LeiomyosarcomaVulvar Squamous Cell Carcinoma
NCT00897442Gynecologic Oncology Group275